| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp. | Director, 10%+ Owner | Class A Common Stock | 3,507,164 | $304,807,623 | $86.91 | 18 Jun 2025 | See Casdin Partners Master Fund, LP |
| STANDARD BIOTOOLS INC. | Director, 10%+ Owner | Common Stock | 59,391,780 | $62,955,286 | $1.06 | 20 Jun 2025 | Casdin Partners Master Fund, L.P |
| GeneDx Holdings Corp. | Director, 10%+ Owner | Class A Common Stock | 333,144 | $28,953,545 | $86.91 | 18 Jun 2025 | See CMLS Holdings LLC |
| Tenaya Therapeutics, Inc. | Director | Common Stock | 6,078,860 | $25,895,944 | $4.26 | 17 Nov 2022 | Indirect |
| STANDARD BIOTOOLS INC. | Director, 10%+ Owner | Common Stock | 13,939,637 | $14,776,015 | $1.06 | 20 Jun 2025 | Casdin Private Growth Equity Fund II, L.P. |
| STANDARD BIOTOOLS INC. | Director, 10%+ Owner | Common Stock | 2,901,062 | $3,075,125 | $1.06 | 20 Jun 2025 | Direct |
| STANDARD BIOTOOLS INC. | Director, 10%+ Owner | Common Stock | 2,744,219 | $2,908,872 | $1.06 | 20 Jun 2025 | By Casdin Private Growth Equity Fund, L.P. |
| GeneDx Holdings Corp. | Director, 10%+ Owner | Class A Common Stock | 20,518 | $1,783,219 | $86.91 | 18 Jun 2025 | Direct |
| GeneDx Holdings Corp. | Director, 10%+ Owner | Class A Common Stock | 19,247 | $1,672,756 | $86.91 | 18 Jun 2025 | See Casdin Partners GP, LLC |
| STANDARD BIOTOOLS INC. | Director, 10%+ Owner | Stock Option (Right to buy) | 125,660 | $270,077 | $3.74 | 20 Jun 2025 | Direct |
| Tenaya Therapeutics, Inc. | Director | Warrant | 1,354,111 | 17 Nov 2022 | Indirect | ||
| Tenaya Therapeutics, Inc. | Director | Stock Option (Right to buy) | 39,727 | 10 Jun 2022 | Direct | ||
| Absci Corp | Director | Stock Option (right to buy) | 28,700 | 08 Jun 2022 | Direct | ||
| Century Therapeutics, Inc. | Director | Stock Option (right to buy) | 19,872 | 09 Jun 2022 | Direct | ||
| EQRx, Inc. | 10%+ Owner | Common Stock | 0 | $2.21 | 09 Nov 2023 | Indirect | |
| EQRx, Inc. | 10%+ Owner | Earn-out Shares | 0 | 09 Nov 2023 | Indirect | ||
| EQRx, Inc. | 10%+ Owner | Stock Option (Right to Buy) | 0 | 09 Nov 2023 | Direct | ||
| EQRx, Inc. | 10%+ Owner | Warrants to purchase Class A Common Stock (right to buy) | 0 | 09 Nov 2023 | Indirect | ||
| GeneDx Holdings Corp. | Director, 10%+ Owner | Restricted Stock Unit | 0 | 18 Jun 2025 | Direct | ||
| SomaLogic, Inc. | Director, 10%+ Owner | Common Stock | 0 | $2.43 | 05 Jan 2024 | By Casdin Master Fund, L.P. | |
| SomaLogic, Inc. | Director, 10%+ Owner | Common Stock | 0 | $2.43 | 05 Jan 2024 | By Casdin Private Growth Equity Fund, L.P. | |
| SomaLogic, Inc. | Director, 10%+ Owner | Common Stock | 0 | $2.43 | 05 Jan 2024 | By CMLS Holdings II LLC | |
| SomaLogic, Inc. | Director, 10%+ Owner | Common Stock | 0 | $2.43 | 05 Jan 2024 | Direct | |
| SomaLogic, Inc. | Director, 10%+ Owner | Restricted Stock Unit | 0 | $2.43 | 05 Jan 2024 | Direct | |
| SomaLogic, Inc. | Director, 10%+ Owner | Stock Option (Right to buy) | 0 | 05 Jan 2024 | Direct | ||
| SomaLogic, Inc. | Director, 10%+ Owner | Warrant to purchase common stock (Right to buy) | 0 | 05 Jan 2024 | By CMLS Holdings II LLC |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC. | 20 Jun 2025 | 2 | $0 | 4 | Director, 10%+ Owner | 24 Jun 2025, 18:57 |
| WGS | GeneDx Holdings Corp. | 18 Jun 2025 | 3 | $0 | 4/A | Director, 10%+ Owner | 07 Aug 2025, 19:41 |
| LAB | STANDARD BIOTOOLS INC. | 19 Jul 2024 | 1 | $0 | 4 | Director, 10%+ Owner | 23 Jul 2024, 18:05 |
| LAB | STANDARD BIOTOOLS INC. | 28 Jun 2024 | 2 | $0 | 4 | Director, 10%+ Owner | 02 Jul 2024, 17:17 |
| WGS | GeneDx Holdings Corp. | 26 Jun 2024 | 1 | $0 | 4 | Director, 10%+ Owner | 27 Jun 2024, 16:14 |
| WGS | GeneDx Holdings Corp. | 20 Jun 2024 | 2 | $0 | 4 | Director, 10%+ Owner | 24 Jun 2024, 19:04 |
| LAB | STANDARD BIOTOOLS INC. | 20 Feb 2024 | 1 | +$57,000 | 4 | Director, 10%+ Owner | 22 Feb 2024, 17:01 |
| /report/000120919124001324-casdin-eli-2024-01-05 | SomaLogic, Inc. | 05 Jan 2024 | 10 | $0 | 4 | Director, 10%+ Owner | 09 Jan 2024, 21:46 |
| LAB | STANDARD BIOTOOLS INC. | 05 Jan 2024 | 10 | $0 | 4 | Director, 10%+ Owner | 09 Jan 2024, 18:06 |
| /report/000091957423006265-casdin-eli-2023-11-09 | EQRx, Inc. | 09 Nov 2023 | 9 | $0 | 4 | 10%+ Owner | 14 Nov 2023, 08:33 |
| WGS | GeneDx Holdings Corp. | 21 Jul 2023 | 2 | $0 | 4 | Director, 10%+ Owner | 25 Jul 2023, 16:14 |
| LAB | STANDARD BIOTOOLS INC. | 14 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 20:49 |
| LAB | STANDARD BIOTOOLS INC. | 17 May 2023 | 3 | +$2,631,335 | 4 | Director, 10%+ Owner | 19 May 2023, 21:02 |
| WGS | GeneDx Holdings Corp. | 02 May 2023 | 2 | $0 | 4 | Director | 04 May 2023, 16:04 |
| /report/000121390023021841-casdin-eli-2023-03-17 | SomaLogic, Inc. | 17 Mar 2023 | 2 | $0 | 4 | Director | 22 Mar 2023, 06:02 |
| WGS | GeneDx Holdings Corp. | 31 Jan 2023 | 2 | +$30,000,000 | 4 | Director, 10%+ Owner | 02 Feb 2023, 15:05 |
| /report/000110465923001112-casdin-eli-2023-01-01 | EQRx, Inc. | 01 Jan 2023 | 3 | $0 | 4 | 10%+ Owner | 04 Jan 2023, 20:55 |
| TNYA | Tenaya Therapeutics, Inc. | 17 Nov 2022 | 2 | +$9,998,644 | 4 | Director | 25 Nov 2022, 18:05 |
| /report/000110465922106014-casdin-eli-2022-09-30 | EQRx, Inc. | 30 Sep 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 04 Oct 2022, 20:24 |
| /report/000091957422007074-casdin-eli-2022-09-29 | SomaLogic, Inc. | 29 Sep 2022 | 1 | $0 | 4 | Director | 14 Dec 2022, 16:40 |
| LAB | STANDARD BIOTOOLS INC. | 15 Jun 2022 | 2 | +$79,182 | 4 | Director | 17 Jun 2022, 18:04 |
| TNYA | Tenaya Therapeutics, Inc. | 10 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 20:45 |
| IPSC | Century Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:22 |
| ABSI | Absci Corp | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:51 |
| WGS | Sema4 Holdings Corp. | 02 May 2022 | 1 | $0 | 4/A | Director | 06 May 2022, 18:56 |
| WGS | Sema4 Holdings Corp. | 29 Apr 2022 | 1 | +$45,750,000 | 4 | Director | 03 May 2022, 16:01 |
| WGS | Sema4 Holdings Corp. | 27 Apr 2022 | 2 | $0 | 4 | Director | 12 May 2022, 20:20 |
| LAB | STANDARD BIOTOOLS INC. | 04 Apr 2022 | 3 | $0 | 4 | Director, 10%+ Owner | 06 Apr 2022, 17:54 |
| LAB | STANDARD BIOTOOLS INC. | 04 Apr 2022 | 0 | $0 | 3 | Director | 06 Apr 2022, 17:53 |
| /report/000106299322006752-casdin-eli-2022-03-01 | SomaLogic, Inc. | 01 Mar 2022 | 2 | $0 | 4 | Director | 03 Mar 2022, 20:08 |
| /report/000089924321049720-casdin-eli-2021-12-17-restatement | EQRx, Inc. | 17 Dec 2021 | 13 | +$50,000,000 | 4/A | Director, 10%+ Owner | 23 Dec 2021, 19:47 |
| /report/000106299321012752-casdin-eli-2021-10-27 | SomaLogic, Inc. | 27 Oct 2021 | 1 | $0 | 4 | Director | 13 Dec 2021, 15:39 |
| WGS | Sema4 Holdings Corp. | 15 Oct 2021 | 2 | $0 | 4 | Director | 19 Oct 2021, 19:19 |
| /report/000121390021046737-casdin-eli-2021-09-01 | SomaLogic, Inc. | 01 Sep 2021 | 5 | +$25,000,000 | 4 | Director | 03 Sep 2021, 20:08 |
| TNYA | Tenaya Therapeutics, Inc. | 03 Aug 2021 | 6 | +$12,750,000 | 4 | Director, 10%+ Owner | 04 Aug 2021, 18:32 |
| TNYA | Tenaya Therapeutics, Inc. | 29 Jul 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 29 Jul 2021, 19:31 |
| ABSI | Absci Corp | 26 Jul 2021 | 7 | -$538,356 | 4 | Director | 28 Jul 2021, 16:30 |
| WGS | Sema4 Holdings Corp. | 22 Jul 2021 | 4 | $0 | 4 | Director | 27 Jul 2021, 06:09 |
| ABSI | Absci Corp | 21 Jul 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 21 Jul 2021, 20:52 |
| IPSC | Century Therapeutics, Inc. | 22 Jun 2021 | 3 | +$15,000,000 | 4 | Director | 22 Jun 2021, 16:31 |
| IPSC | Century Therapeutics, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 16:33 |
| IPSC | Century Therapeutics, Inc. | 17 Jun 2021 | 0 | $0 | 3 | Director | 17 Jun 2021, 17:09 |